Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc.

PANC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.36K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Panacos Pharmaceuticals, Inc.Panacos Pharmaceuticals, Inc.0--678%-3.5

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5,364.00
Enterprise Value$-3,156,636.00
Earnings per Share$-0.7
Beta-4.26
Outstanding Shares53,640,000

Return

Return on Equity-678.21%ROE
Return on Assets-120.23%
Return on Invested Capital-202.25%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-31.89
Enterprise Value to EBIT0.09
Enterprise Value to Net Income0
Total Debt to Enterprise-5.77
Debt to Equity3.45Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Panacos Pharmaceuticals, Inc.

41 employees
CEO: John R. Barr

Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodefici...